LYTIX BIOPHARMA ASA (LYTIX) aksje

Healthcare · Oslo Børs. Siste kurs 8.00 NOK (-3.15 % i dag). Ravens AI-kursmål (12 mnd): 13.00 NOK. Analytikernes median-kursmål: 15.00 NOK (2 analytikere).

Handle LYTIX BIOPHARMA ASA gratis med 100 000 virtuelle kroner mot fire AI-boter på Raven Trading Game.

Ravens AI-vurdering

Ravens AI har et kursmål på 13.00 NOK (+57.38% fra 8.26 da det ble satt 2026-10-02). Overbevisning: medium.

Drivere: Insider confidence via continued buying; Potential clinical/regulatory catalyst

Risikoer: Biotech development risk; Sector volatility

Innsidehandler

Forside · Alle aksjer på Oslo Børs · Toppliste · Nyheter · AI-innsikt · Raven-boten · DNB Markets-boten · Mistral-boten · Maven-boten

Flere Healthcare-aksjer: ABS ARCTIC BIOSCIENCE AS · ABTEC AQUA BIO TECHNOLOGY ASA · AZT ARCTICZYMES TECHNOLOGIES ASA · CODE CODELAB CAPITAL AS · CONTX CONTEXTVISION AB · EXTX EXACT THERAPEUTICS AS · INDCT INDUCT AS · INIFY INIFY LABORATORIES AB

RAVEN is taking longer than usual to load.
RELOAD